Who had the best Q2? How 12 spine, orthopedic companies performed

Alan Condon -   Print  |

Here's a breakdown of how 12 spine and orthopedic companies performed during the second quarter of 2019.

Johnson & Jonson's medical devices segment reported a 6.9 percent sales decrease in the second quarter to $6.4 billion. Overall, second quarter orthopedics sales dropped 1.6 percent to $2.2 billion and worldwide orthopedic sales at the six months end dropped 2 percent to $4.4 billion. U.S. spine sales dropped $1.5 percent to $490 million for the quarter, and worldwide spine sales were down 3

Medtronic reported fourth quarter revenue increased 2 percent to $30.5 billion, however the spine business experienced a slight decline. Fourth quarter spine revenue hit $691 million, a 1.1 percent decrease year over year. When combining the spine sales with sales-related to enabling technologies — Medtronic's robotics, navigation, imaging and powered surgical instruments — spine-related revenue increased in the mid-single digits.

Smith & Nephew reported second quarter revenue increased 3.5 percent in 2019, with a strong performance in the company's emerging markets and sports medicine. The company's revenue hit $1.2 billion for the quarter, including $552 million from the orthopedics line. Orthopedics revenue was up 3.6 percent for the quarter.

Zimmer Biomet reported a net sales decrease of 0.9 percent to $1.99 billion during the second quarter. Spine and craniomaxillofacial sales decreased 6.2 percent year over year to $186 million.

Stryker reported an increase in overall sales, driven by a 3.7 percent jump in orthopedics sales during the second quarter. The company reported net sales increased 9.9 percent to $3.7 billion. Orthopedics sales were up 3.7 percent to $1.3 billion while spine and nanotechnology jumped 18.9 percent to $800 million. For the six months end, overall sales were up 9.2 percent to $7.1 billion

Integra LifeSciences posted second quarter revenues of $384 million, a 4.8 percent increase of the same period for last year. Extremity orthopedics revenues rose 1.2 percent to $22 million while the company reported a 6.1 percent increase in orthopedics and tissue technologies year over year, hitting $134 million.

In the second quarter of 2019, NuVasive reported a 3.7 percent year-over-year boost in revenues. Second-quarter revenues increased to $292.1 million from $281.6 million for the same period last year.

RTI Surgical's worldwide revenues increased 16 percent from $70.7 million in the same period last year to $82.3 million in the second quarter of 2019. The company's second quarter revenues were boosted from a $10.1 million global contribution made from the acquisition of Paradigm Spine, which closed in March.

Xtant Medical reported a net loss of $1.9 million, a 62 percent decrease year-over-year. The company posted $10.5 million in second quarter operating expenses, down 29 percent year-over-year.

SI-Bone posted a 19 percent revenue increase to $16.3 million for the second quarter. Gross profit was up 18 percent year over year to $14.8 million. The company also reported a net loss of $8.7 million during the second quarter, a 175 percent increase from the same period last year.

Alphatec posted a second quarter total net revenue of $27.3 million, a 28 percent increase for the same period last year. Total operating expenses rose 32.6 percent to $29.3 million and net loss increased 75.8 percent to $12.4 million when compared with the same period last year.

Orthofix reported net sales increased 3.9 percent in the second quarter, including $500,000 in sales of the M6-C cervical disc. The company's net sales hit nearly $116 million, an almost 4 percent increase over the same period last year.

More articles on devices:
Why Dr. Dominic Thomas Kleinhenz joined University Orthopedics and the biggest obstacle in spine
Dr. Stephen Hochschuler: Future trends in spine – telemedicine, robotics, AI & more
Dr. Christopher Kager: The standout spine procedure in his career, future of biologics & more

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers